[1] JIA WeigangPAN ZhichaoGUAN HuiminHAN YunyiZHANG BihaiXIAO Furong,.Clinical Evaluation of Kangfei Exercises on the Effectof Common COVID-19 Patients in the Recovery Period [J]. Modern Traditional Chinese Medicine, 2024, (04): 49-55. [doi: 10.13424/j.cnki.mtcm.2024.04.010]
Clinical Evaluation of Kangfei Exercises on the Effectof Common COVID-19 Patients in the Recovery Period
- Article number:
- 1672-0571(2024)04-0049-07
- Keywords:
- Key words:Kangfei exercise; Common COVID-19; Barthel score; Hamilton scale; Re positivity rate; Superior effectiveness
- ZTFLH:
- R256.1
- Code:
- A
- Abstract:
- Abstract：Objective To evaluate the intervention effect of Kangfei exercise lung rehabilitation training on patients with common COVID-19 in the rehabilitation period. Methods 90 patients with common COVID-19 who met the requirements were randomly divided into 1∶1 groups. The treatment group received intervention with lung exercises, while the control group received routine intervention with Ba Duan Jin and Liu Zi Jue. All interventions lasted for 7 days. Measure the FS score, Borg score, lung CT inflammation score, Barthel score, Hamilton Anxiety and Depression score (HAMA, HAMD) before and after intervention, and observe the time to nucleic acid negative (d), length of hospital stay, and rate of re positivity.Results The FS score, HAMD score, and Barthel score of the treatment group (45 cases) and the control group (35 cases) after intervention were (2.19±0.09 vs 1.05±0.51), (6.56±0.17 vs 9.17±1.19), and (99.89±1.32 vs 93.25±1.37), respectively. The time to nucleic acid negative conversion (d) and the rate of re positivity were (11.11±0.24 vs 13.04±0.91) and (2.38% vs 15.78%), and the differences were statistically significant (P<0.05). The Borg score, lung CT inflammation score, HAMA score, and length of hospital stay were (0.41±0.27 vs 0.68±0.12), (0.96±0.08 vs 1.01±0.51), (7.11±0.71 vs 7.21±0.78), and (13.23±1.37 vs 14.12±1.56), respectively, with no statistically significant differences (P>0.05).Conclusion Pulmonary rehabilitation training can promote the absorption of pulmonary inflammation, relieve dyspnea symptoms and improve anxiety in patients with common COVID-19 at the recovery stage. The effect of lung exercises on improving depression is superior to conventional exercises, and it has practical clinical advantages in improving quality of life and pleasure, as well as its effectiveness. It can significantly shorten the time for nucleic acid to turn negative and reduce the rate of re positivity.
References:
［1］中华医学会老年医学分会老年康复学组,中国心理学会康复心理学专业委员会,中国医院协会医疗康复机构管理分会,等.基于世界卫生组织国际健康分类家族架构的2019冠状病毒病康复方案专家共识［J］.中国康复理论与实践,2020,26(10):1117-1126.
［2］贾维刚,周泉宇,塔娜,等.161例北方新型冠状病毒肺炎中医病证特点及病因病机分析［J］.中国中医急症,2021,30(8):1333-1335,1360.
［3］张焕,何超宇,陈豪诚,等.新冠病毒感染者康复期焦虑抑郁失眠状况及影响因素的回顾性分析［J］.临床精神医学杂志,2023,33(6):444-447.
［4］EVERAERTS S,HEYNS A,LANGER D,et al.COVID-19 recovery:benefits of multidisciplinary respiratory rehabilitation［J］.BMJ Open Respiratory Research,2021,8(1):e000837.
［5］杨菊,杨茜,高玲,等.COVID-19肺炎患者应用肺康复的可能性探讨［J］.四川生理科学杂志,2020,42(4):512-515.
［6］中国康复医学会,中国康复医学会呼吸康复专委会,中华医学会物理医学与康复学分会心肺康复学组. 2019新型冠状病毒肺炎呼吸康复指导意见(第二版)［J］.中华结核和呼吸杂志,2020,43(4):308-314.
［7］王超臣,杨宇,冉启杰,等.呼吸肌康复训练用于新冠肺炎治疗的探讨［J］.人民军医,2020,63(4):358-361.
［8］MACCARONE MC,MASIERO S.Spa therapy interventions for post respiratory rehabilitation in COVID-19 subjects:does the review of recent evidence suggest a role?［J］.Environmental Science and Pollution Research International,2021,28(33):46063-46066.
［9］REINA-GUTIRREZ S,TORRES-COSTOSO A,MARTNEZ-VIZCANO V,et al.Effectiveness of pulmonary rehabilitation in interstitial lung disease,including coronavirus diseases:a systematic review and meta-analysis［J］.Archives of Physical Medicine and Rehabilitation,2021,102(10):1989-1997.e3.
［10］MALDANER V,COUTINHO J,DA CRUZ SANTANA AN,et al.Adjunctive inspiratory muscle training for patients with COVID-19 (COVIDIMT):protocol for randomised controlled double-blind trial［J］.BMJ Open,2021,11(9):e049545.
［11］朱慧芹,柳春阳,李鸿宇,等.新型冠状病毒肺炎患者的呼吸康复建议［J］.哈尔滨医药,2020,40(6):588-590.
［12］贾维刚,周泉宇,肖芙蓉,等.96例北方普通型新型冠状病毒肺炎中医证候特点及方案汤剂治疗效果观察［J］.湖南中医药大学学报,2021,41(10):1559-1563.
［13］中华人民共和国国家卫生健康委.新型冠状病毒肺炎诊疗方案(试行第九版)［J］.中华临床感染病杂志,2022,15(2):81-89.
［14］黑龙江省中医药管理局.关于印发黑龙江省新型冠状病毒肺炎中医药防治方案(2021版) 的通知［EB/OL］（2021-01-28）［2021-02-15］.https://www.hlj.gov.cn/n200/2021/0205/c664-11014525.html.
［15］WILMORE JACK H,COSTILL DAVID L,GLEIM GILBERT W.Physiology of Sport and Exercise［J］.Medicine & Science in Sports & Exercise,1995:524.
［16］ABBISS CR,LAURSEN PB.Describing and understanding pacing strategies during athletic competition［J］.Sports Medicine,2008,38(3):239-252.
［17］中华医学会心血管病学分会,中华心血管病杂志编辑委员会.肺动脉高压筛查诊断与治疗专家共识［J］.中华心血管病杂志,2007,35(11):979-987.
［18］MAHONEY FI,BARTHEL DW.Functional evaluation:the barthel index［J］.Maryland State Medical Journal,1965,14:61-65.
［19］曹雪,袁军民,陈宁君,等.新型冠状病毒肺炎病因病机、辨证分型探析［J］.现代中医药,2020,40(2):1-4.
［20］孟方方,李耀辉,王艳,等.新型冠状病毒肺炎病因病机探析［J］.现代中医药,2022,42(6):62-66.
［21］王露露,肖洋,祁海燕,等.浅析《伤寒论》“存津液” 思想在“三方” 治疗新型冠状病毒肺炎中的体现［J］.现代中医药,2023,43(4):20-25.
［22］CARF A,BERNABEI R,LANDI F.Persistent symptoms in patients after acute COVID-19［J］.JAMA,2020,324(6):603-605.
［23］SHI SB,QIN M,SHEN B,et al.Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan,China［J］.JAMA Cardiology,2020,5(7):802-810.
［24］GRIGOLETTO I,CAVALHERI V,LIMA FF,et al.Recovery after COVID-19:the potential role of pulmonary rehabilitation［J］.Brazilian Journal of Physical Therapy,2020,24(6):463-464.
［25］蒋胜华,李丕宝,陈莉,等.呼吸康复训练在重型危重型新型冠状病毒肺炎患者恢复期的应用价值［J］.中华诊断学电子杂志,2020,8(3):186-190.
［26］ROCHESTER CL,SPRUIT MA,HOLLAND AE.Pulmonary rehabilitation in 2021［J］.JAMA,2021,326(10):969-970.
［27］沈娅妮,魏莉莉,荆志忻,等.呼吸训练对慢性阻塞性肺疾病合并呼吸衰竭患者有效性的系统评价［J］.中国康复医学杂志,2021,36(2):186-192.
［28］周柳吟,严娇,何琦,等.基于ITHBC的个体化呼吸训练及营养支持在COPD患者中的应用研究［J］.中国急救复苏与灾害医学杂志,2024,19(2):242-246.
［29］王晶晶,茅靖.扶正固表法配合肺康复锻炼对慢性阻塞性肺疾病稳定期的影响［J］.现代中医药,2022,42(2):95-98.
［30］刘学琼.老年急性加重期慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者早期肺康复模式研究进展［J］.老年医学与保健,2023,29(4):860-865.
［31］娄虎,颜军.重大传染病疫情中体育锻炼对应激心理神经免疫的路径与对策［J］.中国体育科技,2020,56(5):35-40,89.
［32］周海旺,陈新胜,杜思思,等.中药配合艾灸治疗41例新冠肺炎愈后“复阳” 患者的临床观察［J］.现代中医药,2021,41(3):55-59.
Memo
基金项目：国家科技重大专项（2017ZX10305501-011-002）；国家科技部项目（2020YFC0841600）；国家中医药管理局中医药防治新型冠状病毒肺炎专项课题（2020ZYLCYJ06-3）；黑龙江省中医药科研项目（ZHY2022-070）